Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation

Arnljot Tveit; Ingebjørg Seljeflot; Irene Grundvold; Michael Abdelnoor; Pal Smith; Harald Arnesen

doi:10.1016/j.thromres.2007.06.014

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation

Arnljot Tveit, Ingebjørg Seljeflot, Irene Grundvold, Michael Abdelnoor, Pal Smith, Harald Arnesen

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Original language	English
Pages (from-to)	447-453
Number of pages	7
Journal	Thrombosis Research
Volume	121
Issue number	4
DOIs	https://doi.org/10.1016/j.thromres.2007.06.014
State	Published - 2008
Externally published	Yes

Access to Document

10.1016/j.thromres.2007.06.014

Cite this

@article{12d4038074cb4771b2cb201c783197ca,

title = "Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation",

author = "Arnljot Tveit and Ingebj{\o}rg Seljeflot and Irene Grundvold and Michael Abdelnoor and Pal Smith and Harald Arnesen",

note = "Funding Information: We are indebted to the clinical research nurses Mona Olufsen and Anne Kari Brun and to medical laboratory technologist Theresa Mai for excellent technical assistance. The study was sponsored by the Regional Health Corporation of Eastern Norway, and the Medical Research Foundation, Asker and Baerum Hospital, Norway. AstraZeneca, Molndal, Sweden provided the study medication, and AstraZeneca, Oslo, Norway, provided a grant to cover for laboratory analyses. Funding Information: First author Arnljot Tveit received a two-year full time research grant from The Regional Health Corporation of Eastern Norway. The Medical Research Foundation, Asker and Baerum Hospital, Norway provided grants for study nurse and technical equipment. AstraZeneca, Molndal, Sweden provided the study medication. AstraZeneca, Oslo, Norway, supported the study with a grant to cover for laboratory analyses. The CAPRAF study group (comprising the authors of this manuscript) was responsible for study design, collection, analysis and interpretation of data, and writing of the manuscript. AstraZeneca representatives were invited to comment on study design and the manuscript, however were neither involved in the conduct of the study nor the decision to submit the manuscript for publication. ",

year = "2008",

doi = "10.1016/j.thromres.2007.06.014",

language = "English",

volume = "121",

pages = "447--453",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation

AU - Tveit, Arnljot

AU - Seljeflot, Ingebjørg

AU - Grundvold, Irene

AU - Abdelnoor, Michael

AU - Smith, Pal

AU - Arnesen, Harald

N1 - Funding Information: We are indebted to the clinical research nurses Mona Olufsen and Anne Kari Brun and to medical laboratory technologist Theresa Mai for excellent technical assistance. The study was sponsored by the Regional Health Corporation of Eastern Norway, and the Medical Research Foundation, Asker and Baerum Hospital, Norway. AstraZeneca, Molndal, Sweden provided the study medication, and AstraZeneca, Oslo, Norway, provided a grant to cover for laboratory analyses. Funding Information: First author Arnljot Tveit received a two-year full time research grant from The Regional Health Corporation of Eastern Norway. The Medical Research Foundation, Asker and Baerum Hospital, Norway provided grants for study nurse and technical equipment. AstraZeneca, Molndal, Sweden provided the study medication. AstraZeneca, Oslo, Norway, supported the study with a grant to cover for laboratory analyses. The CAPRAF study group (comprising the authors of this manuscript) was responsible for study design, collection, analysis and interpretation of data, and writing of the manuscript. AstraZeneca representatives were invited to comment on study design and the manuscript, however were neither involved in the conduct of the study nor the decision to submit the manuscript for publication.

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=38649136223&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2007.06.014

DO - 10.1016/j.thromres.2007.06.014

M3 - Article

C2 - 17698170

AN - SCOPUS:38649136223

SN - 0049-3848

VL - 121

SP - 447

EP - 453

JO - Thrombosis Research

JF - Thrombosis Research

IS - 4

ER -